FIELD OF THE INVENTION
This invention relates to treating and alleviating joint pain and symptoms of osteoarthritis and/or rheumatoid arthritis.
BACKGROUND OF THE INVENTION
The use of krill oil is disclosed in U.S. Patent Publication Nos. 2004/0234587; 2004/0241249; and 2007/0098808, the disclosures
FIELD OF THE INVENTION
This invention relates to methods for treating joint pain associated with inflammatory, degenerative and other joint diseases.
BACKGROUND OF THE INVENTION
Over 20 million people in the United States suffer from degenerative joint diseases. This results in over 2 million
FIELD OF THE INVENTION
The invention relates to methods of diagnosis, control and prophylaxis of inflammation and mitigation of inflammatory conditions, particularly arthritis and joint pain, in canines, comprising measuring inflammatory biomarkers wherein elevated levels of the biomarkers in blood
FIELD OF THE INVENTION
This invention relates to treating and alleviating joint pain and symptoms of osteoarthritis and/or rheumatoid arthritis.
BACKGROUND OF THE INVENTION
The use of krill oil is disclosed in U.S. Patent Publication Nos. 2004/0234587; 2004/0241249; and 2007/0098808, the disclosures
FIELD OF THE INVENTION
This invention relates to treating and alleviating joint pain and symptoms of osteoarthritis and/or rheumatoid arthritis.
BACKGROUND OF THE INVENTION
The use of krill oil is disclosed in U.S. Patent Publication Nos. 2004/0234587; 2004/0241249; and 2007/0098808, the disclosures
FIELD OF THE INVENTION
This invention relates to treating and alleviating joint pain and symptoms of osteoarthritis and/or rheumatoid arthritis.
BACKGROUND OF THE INVENTION
The use of krill oil is disclosed in U.S. Patent Publication Nos. 2004/0234587; 2004/0241249; and 2007/0098808, the disclosures
FIELD OF THE INVENTION
This invention relates to treating and alleviating joint pain and symptoms of osteoarthritis and/or rheumatoid arthritis.
BACKGROUND OF THE INVENTION
The use of krill oil is disclosed in U.S. Patent Publication Nos. 2004/0234587; 2004/0241249; and 2007/0098808, the disclosures
FIELD OF THE INVENTION
The present invention relates to a group of novel pharmaceutically acceptable salts, each containing local anesthetic and anti-inflammatory activities. The preferred pharmaceutical acceptable salt in this group is diclofenac salt of lidocaine. Diclofenac is a non-steroidal
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to a pharmaceutical composition comprising aqueous extracts of Anemarrhena Rhizoma, a member of the family Liliaceae, and Phellodendron Bark, a member of the family Lilium for analgesic and
FIELD OF THE INVENTION
This invention relates to the use of corticosteroids to treat pain, including pain caused by inflammatory diseases such as osteoarthritis or rheumatoid arthritis, and to slow, arrest or reverse structural damage to tissues caused by an inflammatory disease, for example damage
FIELD OF THE INVENTION
This invention relates to the use of corticosteroids to treat pain, including pain caused by inflammatory diseases such as osteoarthritis or rheumatoid arthritis, and to slow, arrest or reverse structural damage to tissues caused by an inflammatory disease, for example damage
FIELD OF THE INVENTION
This invention relates to the use of corticosteroids to treat pain, including pain caused by inflammatory diseases such as osteoarthritis or rheumatoid arthritis, and to slow, arrest or reverse structural damage to tissues caused by an inflammatory disease, for example damage
FIELD OF THE INVENTION
This invention relates to the use of corticosteroids to treat pain, including pain caused by inflammatory diseases such as osteoarthritis or rheumatoid arthritis, and to slow, arrest or reverse structural damage to tissues caused by an inflammatory disease, for example damage
FIELD OF THE INVENTION
This invention relates to the use of corticosteroids to treat pain, including pain caused by inflammatory diseases such as osteoarthritis or rheumatoid arthritis, and to slow, arrest or reverse structural damage to tissues caused by an inflammatory disease, for example damage
TECHNICAL FIELD
The present invention relates, in general, to novel benzoimidazole derivatives and, more particularly, to novel benzoimidazole derivatives functioning as antagonists to a vanilloid receptor (capsaicin receptor; Transient Receptor Potential Channel, Vanilloid subfamily member 1;
The most complete medicinal herbs database backed by science
Works in 55 languages
Herbal cures backed by science
Herbs recognition by image
Interactive GPS map - tag herbs on location (coming soon)
Read scientific publications related to your search
Search medicinal herbs by their effects
Organize your interests and stay up do date with the news research, clinical trials and patents
Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against. *All information is based on published scientific research